Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature

13Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Gemcitabine-induced radiation recall (GIRR) is a phenomenon wherein the administration of gemcitabine induces an inflammatory reaction within an area of prior radiation. We present the case of a 39-year-old female patient with metastatic breast cancer who experienced GIRR myositis 3 months following postoperative radiotherapy, with additional potential paraspinal myositis following ablative radiotherapy to the thoracic spine. A review of previously published cases of GIRR myositis was performed. The case and literature review describe the clinical course and presentation of GIRR, and highlight the importance of including radiation recall as part of a differential diagnosis when a patient undergoing chemotherapy experiences an inflammatory reaction at a prior site of radiation.

Cite

CITATION STYLE

APA

Ravishankar, A., Park, S. S., Olivier, K. R., & Corbin, K. S. (2018). Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature. Case Reports in Oncology, 11(1), 168–178. https://doi.org/10.1159/000487478

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free